...
首页> 外文期刊>Naunyn-Schmiedeberg's Archives of Pharmacology >Autoreceptors can modulate 5-hydroxytryptamine release from porcine and human small intestine in vitro.
【24h】

Autoreceptors can modulate 5-hydroxytryptamine release from porcine and human small intestine in vitro.

机译:自身受体可以在体外调节猪和人小肠中的5-羟色胺释放。

获取原文
获取原文并翻译 | 示例
           

摘要

The effects of 5-hydroxytryptamine (5-HT) receptor agonists and antagonists were studied on the release of 5-HT from enterochromaffin cells of incubated strips of porcine and human small intestine. Tetrodotoxin (1 micromol/l) was present in the incubation medium to block neuronally mediated inputs to the enterochromaffin cells. The 5-HT1A receptor agonist (+)-8-hydroxy-dipropylaminotetralin (8-OH-DPAT, 1 micromol/l) and the 5-HT2 receptor agonist alpha-methyl-5-HT (1 micromol/l) increased 5-HT release by 40% in about 60% of the human preparations.These agonists showed no effect on 5-HT release in porcine intestinal mucosa. The 5-HT3 receptor agonist 2-methyl-5-HT (3-100 micromol/l) increased 5-HT release in both species by 60% (pig) and 90% (man), respectively. These stimulatory effects were antagonized by tropisetron (10 nmol/l). The 5-HT4 receptor agonist 5-methoxytryptamine (0.3-30 micromol/l) reduced 5-HT release by about 50% in both species. These inhibitory effects were antagonized by tropisetron (3 micromol/l). The basal outflow of 5-HT from the intestinal mucosa was not significantly affected by tropisetron (10 nmol/l; 3 micromol/l). The specific 5-HT4 receptor antagonist GR 113808 ((1-[2-methylsulphonyl)amino]ethyl]-4-piperidinyl]methyl-1-methyl-1H-ind ole-3-carboxylate) (0.1 micromol/l) which by itself did not significantly affect 5-HT release from human duodenal specimens blocked the inhibitory effect of 5-methoxytryptamine (30 micromol/l). These findings indicate that stimulatory 5-HT3 and inhibitory 5-HT4 receptors are present on enterochromaffin cells of the porcine and human intestinal mucosa. Under the present experimental conditions endogenous 5-HT does not significantly activate these receptors. Stimulatory 5-HT1A and 5-HT2 receptors may additionally be present on human enterochromaffin cells.
机译:研究了5-羟色胺(5-HT)受体激动剂和拮抗剂对猪和人小肠培养条中肠嗜铬细胞释放5-HT的影响。河豚毒素(1微摩尔/升)存在于孵育培养基中,以阻止神经元介导的输入至肠嗜铬细胞的输入。 5-HT1A受体激动剂(+)-8-羟基二丙基氨基四氢萘(8-OH-DPAT,1 micromol / l)和5-HT2受体激动剂α-甲基-5-HT(1 micromol / l)增加5-约60%的人类制剂中HT释放40%。这些激动剂对猪肠道粘膜中的5-HT释放没有影响。 5-HT3受体激动剂2-甲基-5-HT(3-100 micromol / l)分别使两种物种的5-HT释放增加60%(猪)和90%(人)。这些刺激作用被托吡司琼(10nmol / l)拮抗。 5-HT4受体激动剂5-甲氧基色胺(0.3-30 micromol / l)降低了这两种物种中5-HT的释放量约50%。这些抑制作用被托吡司琼(3 micromol / l)拮抗。托吡司琼(10 nmol / l; 3 micromol / l)对肠粘膜5-HT的基础流出没有显着影响。特定的5-HT4受体拮抗剂GR 113808((1- [2-甲基磺酰基)氨基]乙基] -4-哌啶基]甲基-1-甲基-1H-吲哚-3-羧酸酯)(0.1微摩尔/升)本身并没有显着影响人十二指肠标本中5-HT的释放,阻止了5-甲氧基色胺(30 micromol / l)的抑制作用。这些发现表明在猪和人肠粘膜的肠嗜铬细胞上存在刺激性5-HT 3和抑制性5-HT 4受体。在目前的实验条件下,内源性5-HT不会显着激活这些受体。刺激性5-HT1A和5-HT2受体可能还存在于人肠嗜铬细胞上。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号